Top Private Equity-Backed Healthcare Services Acquirers

Tracked deals

3346

3346 tracked deals across 2008-2026.

Buyer mix

Mixed buyer set

3265 pe · 1953 strategic

Top trend

Volume peaked in 2021

578 tracked deals announced in 2021.

Buyer Snapshot

Top Buyers

Illustrative buyers pulled from tracked transactions on this page. This table is capped and intentionally non-exhaustive.

Build a buyer list for your Healthcare Services deal →
Buyer # Deals Focus Type
NMS Capital 64 Private equity firm focused on lower middle market invest... PE
The Riverside Company 29 Global private equity firm focused on the smaller end of ... PE
Gryphon Investors 28 Middle-market private equity firm and sponsor; provides c... PE
Revelstoke Capital Partners 26 Healthcare-focused private equity firm that partners with... PE
Sheridan Capital Partners 25 Chicago-based healthcare private equity firm focused on l... PE
H.I.G. Capital 22 Global alternative investment firm providing equity and d... PE
HCAP Partners 22 Southern California-based private equity and mezzanine de... PE
Linden Capital Partners 22 Healthcare-focused private equity firm investing in middl... PE
InTandem Capital Partners 21 Private equity firm focused on investing in and growing h... PE
Ampersand Capital Partners 20 Middle-market private equity firm focused on growth-orien... PE

Acquisition Volume in Private Equity-Backed Healthcare Services by Year

Last 10 years

Acquisition volume by year Annual acquisition counts for the last 10 years for Top Private Equity-Backed Healthcare Services Acquirers. 16 2017 26 2018 269 2019 354 2020 578 2021 557 2022 411 2023 401 2024 396 2025 ~425 est. 304 2026
Actual Full-year estimate

Supporting Data

Recent Transactions

  • Buyer
    Kincellis Advanced Therapies, NewSpring Capital, Kineticos Life Sciences, HealthQuest Capital, Great Point Partners, J.P. Morgan
    Target
    Kincell Bio, Cellipont Bioservices
    Location
    United States
    Type
    Buyout

    Kincell Bio and Cellipont Bioservices completed their merger to create Kincellis Advanced Therapies, a scaled U.S. contract development and manufacturing organization (CDMO) focused on cell therapies and other advanced modalities. The combined platform spans early development through commercial supply across multiple sites in Florida, North Carolina, and Texas, with the equity financing led by NewSpring Capital and debt support from J.P. Morgan.

  • September 17, 2026
    Buyer
    Allyant, Thompson Street Capital Partners
    Target
    Braille Works
    Type
    Addon

    Allyant acquired Braille Works, expanding its alternative-format production capabilities across braille, large print, audio, and accessible PDFs. The transaction also increases Allyant’s capacity and adds a Florida production presence, while preserving Braille Works’ accessibility-focused operating model. Financial terms were not disclosed.

  • Buyer
    Everest Clinical Research, Arlington Capital Partners
    Target
    Firma Clinical Research (Biometrics and Data Services business unit)
    Seller
    Firma Clinical Research
    Location
    Ontario, Canada
    Type
    Buyout

    Everest Clinical Research (“Everest”) announced the acquisition of the Biometrics and Data Services business unit of Firma Clinical Research (“Firma DS”). The deal expands Everest’s global biometrics expertise and clinical data science capabilities, adding an experienced biometrics team and supporting clients across the clinical development lifecycle.

  • Buyer
    L Catterton, Altas Partners
    Target
    Fullscript
    Seller
    HGGC, Snapdragon Capital Partners
    Location
    Ontario, Canada
    Type
    Buyout

    L Catterton and Altas Partners agreed to acquire a majority stake in Fullscript from HGGC and Snapdragon Capital Partners. The investment is intended to support Fullscript’s next phase of expansion, including growth of its platform and clinical support capabilities, ahead of a planned close in Q4 2026 subject to regulatory approvals and customary conditions.

  • Buyer
    Toscafund Asset Management, Three Hills, Ares
    Target
    Spire Healthcare Group
    Location
    United Kingdom
    Type
    Buyout

    Spire Healthcare Group has agreed to be acquired by a consortium of funds managed by Toscafund Asset Management, Three Hills and Ares in a deal valuing the UK private healthcare operator at about £1.026 billion. The consortium will pay 250 pence per Spire share, representing a 66% premium to the company’s market capitalization on May 13, and shareholders holding about 53.4% have agreed to support the offer.

  • Buyer
    LUX Infusion, Frazier Healthcare Partners
    Target
    South Jersey Pediatric and Adult Infusion Center, Northeast Infusion Therapy
    Type
    Addon

    LUX Infusion acquired two ambulatory infusion centers—South Jersey Pediatric and Adult Infusion Center in Cherry Hill, New Jersey and Northeast Infusion Therapy in Latham, New York. The acquisitions expand LUX Infusion’s ambulatory infusion center footprint and support its clinician-led model of patient-centered, physician-collaborative infusion care.

  • Buyer
    Hanger, Inc., Patient Square Capital
    Target
    Numotion
    Type
    Buyout

    Hanger has agreed to acquire Numotion for cash, combining orthotic and prosthetic patient care with Complex Rehabilitation Technology (CRT) and mobility and independence solutions. The combined organization will continue operating under existing brands and is expected to close in the fourth quarter of 2026, subject to customary conditions.

  • Buyer
    Danforth Health, Inc.
    Target
    Ambit RD, Inc.
    Seller
    Clearsight Advisors, Inc. (exclusive sell-side advisor)
    Type
    Addon

    Danforth Health, Inc., a portfolio company of Avesi Partners, acquired Ambit RD, Inc. Ambit is a technology-enabled solutions provider focused on serving rare and specialty biopharma markets with commercial strategy, advanced analytics, and patient identification solutions.

  • Buyer
    Olympus Cosmetic Group
    Target
    Gallaher Plastic Surgery & Med Spa
    Seller
    Dr. Tom Gallaher
    Type
    Addon

    Olympus Cosmetic Group acquired Gallaher Plastic Surgery & Med Spa, a cosmetic plastic surgery and med spa practice in Eastern Tennessee. The deal expands Olympus’ surgeon-founded aesthetics platform into Tennessee, with the practice continuing under its physician-led approach led by Dr. Tom Gallaher.

  • Buyer
    Lee Equity Partners, LLC
    Target
    Marwood Group
    Location
    United States

    Marwood Group, a healthcare-focused advisory and consulting firm, received a strategic investment from funds managed by Lee Equity Partners. The firm also named Chris Librizzi as Chief Executive Officer, alongside Richard Jeanneret joining as Executive Chairman.

  • Buyer
    H.I.G. Capital
    Target
    Outcomes One
    Type
    Buyout

    H.I.G. Capital, through an affiliate, completed the acquisition of Outcomes One (Outcomes), an Orlando-based provider of clinical network services and pharmacy technology. Outcomes operates a national clinical network covering about 85% of U.S. pharmacies and offers an integrated technology suite including pharmacy management software and workflow automation platforms such as Rx30, Computer-Rx, and Outcomes Premium.

  • Buyer
    Liberty Restoration Group, MBN Brands, Petra Capital Partners, SharpVue Capital
    Target
    ServiceMaster Restoration Services by KRS
    Type
    Addon

    Liberty Restoration Group has completed its acquisition of ServiceMaster Restoration Services by KRS, adding three new offices in Peoria and Bloomington, Illinois, and Milwaukee, Wisconsin. The deal expands Liberty’s multi-market disaster restoration and reconstruction platform to eight Midwest markets following its April acquisition of ServiceMaster of Columbia in Missouri.

  • Buyer
    BPOC
    Target
    Master Medical Equipment, ReNew Biomedical

    BPOC, a healthcare-focused investment firm, made strategic investments in Master Medical Equipment (MME) and ReNew Biomedical, sister companies that distribute, rent, repair, and maintain medical equipment. The companies plan to use BPOC’s backing to expand their geographic footprint and broaden their range of healthcare equipment and service solutions, with founder and CEO Mark Taylor continuing to lead both businesses.

  • Buyer
    Starry Sea Acquisition Corp.
    Target
    SuperiorMed Holdings
    Location
    United Arab Emirates

    SuperiorMed Holdings entered into a definitive merger agreement with Starry Sea Acquisition Corp., expected to take the Dubai-based healthcare management and services platform public via a SPAC transaction. Under the structure, Starry Sea will merge with and into SuperiorMed Healthcare Group, and a separate merger subsidiary will combine with SuperiorMed, leaving SuperiorMed as a wholly owned subsidiary of the publicly listed parent.

  • Buyer
    Linden Capital Partners
    Target
    ArtesRx, LLC
    Seller
    Flexpoint Ford
    Location
    United States
    Type
    Buyout

    Linden Capital Partners has acquired ArtesRx, a behavioral health pharmacy platform, from Flexpoint Ford. ArtesRx was founded in 2023 and expanded its footprint from three pharmacies in one state to 16 pharmacies serving patients across 15 states.

  • Buyer
    Seacoast Capital
    Target
    Aarista

    Seacoast Capital announced a non-control growth capital investment in Aarista to support a balance sheet recapitalization. The firm provided subordinated debt to help recapitalize certain existing indebtedness and provide working capital for Aarista’s continued growth.

  • Buyer
    Francisco Partners
    Target
    Weave Communications, Inc.
    Type
    Buyout

    Francisco Partners has entered into a definitive agreement to acquire Weave Communications for approximately $650 million in an all-cash transaction at $7.40 per share, representing about a 34% premium. The deal is expected to close in the fourth quarter of 2026, after stockholder and regulatory approvals, and Weave will become private and cease trading on the NYSE.

  • Buyer
    New Heritage Capital
    Target
    Carepoint Pharmacy

    Carepoint Pharmacy, an end-to-end access hub and dispensing pharmacy, announced a partnership and investment from New Heritage Capital. The investment uses Heritage’s “Private IPO” structure, which is designed to leave operating control with Carepoint’s current management while providing financial flexibility for growth. Terms were not disclosed.

  • Buyer
    JLL Partners
    Target
    Life Couriers
    Seller
    An affiliate of AUCTUS Capital Partners
    Location
    Bavaria, Germany
    Type
    Buyout

    JLL Partners completed its acquisition of Life Couriers, a Munich-headquartered provider of time-critical healthcare logistics for radiopharmaceutical and life sciences shipments. The deal also includes the appointment of Edward DeMartini as CEO as Life Couriers plans to expand its geographic footprint with additional investment in people and operations.

  • Buyer
    DocGo Inc., Perceptive Advisors
    Target
    Hicuity Health
    Location
    United States
    Type
    Buyout

    DocGo has entered into a definitive agreement to acquire Hicuity Health, a virtual care provider offering high acuity virtual clinical services including Tele-ICU and virtual nursing. DocGo will acquire Hicuity in exchange for assuming Hicuity’s existing indebtedness (held by Perceptive Advisors) and Perceptive Advisors will also commit additional debt financing to DocGo.

  • Buyer
    Blackstone, KKR & Co.
    Target
    Affordable Care, LLC
    Seller
    Harvest Partners, Berkshire Partners

    Affordable Care, LLC, a national dental support organization (DSO), completed a sweeping debt restructuring that removes more than $1 billion of debt and injects $75 million in fresh capital. Under the terms, the former private equity sponsors are wiped out and the reorganized company is owned by its direct lenders, including Blackstone and KKR & Co.

  • Buyer
    The Riverside Company
    Target
    Yellow Emperor
    Type
    Addon

    The Riverside Company has invested in Yellow Emperor, a contract development and manufacturing organization (CDMO) specializing in custom liquid dietary supplement formulations. The deal represents the first add-on investment for Riverside’s portfolio company, Western Botanicals, expanding its liquid manufacturing capabilities and positioning it as a broader formulator and manufacturing partner for health and wellness brands.

  • Buyer
    Surplus Solutions LLC, NMS Capital, TPG Twin Brook Capital Partners
    Target
    Boston Industries
    Type
    Addon

    Surplus Solutions LLC, an NMS Capital portfolio company, acquired Boston Industries, a Walpole, Massachusetts-based specialist in technical repair and refurbishment of laboratory instruments. The deal expands Surplus Solutions’ in-house lab repair capabilities across flow cytometry, microscopy, liquid handling, and other core instrument categories. Terms were not disclosed.

  • Buyer
    Currier Plastics, Sheridan Capital Partners
    Target
    Sage Product Development
    Seller
    None mentioned
    Type
    Addon

    Currier Plastics (portfolio company of Currier Plastics) has completed the strategic acquisition of Sage Product Development, an engineering, design, and development provider focused on medical devices. Sage’s services span early concept and feasibility, product development and project management, and contract manufacturing for a wide range of device types.

  • Buyer
    Tortuga Growth Partners (TGP)
    Target
    Advanced eClinical Training (ACT)
    Location
    United States

    Tortuga Growth Partners (TGP) made a strategic investment in Advanced eClinical Training (ACT), an online provider of healthcare certifications and workforce development. The deal is intended to accelerate ACT’s national scaling of technology-enabled training and certification programs that prepare frontline clinical professionals, addressing a growing U.S. healthcare labor shortage.

  • Buyer
    KKR
    Target
    Medicover India
    Seller
    Medicover AB
    Location
    India
    Type
    Buyout

    KKR has signed definitive agreements to acquire Medicover India, the Indian hospital operations of Medicover AB, which operates 24 hospitals with approximately 4,800 beds across South and West India. KKR plans to support the hospital operator’s next phase of growth by investing in talent, technology, infrastructure, and clinical capabilities, while reinforcing clinical governance and operating standards.

  • Buyer
    ClaimsBridge, Eir Partners Capital
    Target
    DialysisPPO
    Location
    United States
    Type
    Addon

    ClaimsBridge announced a strategic investment from Eir Partners Capital to scale its end-to-end claim and network technology ecosystem for healthcare payers. In parallel, ClaimsBridge acquired DialysisPPO, which offers a patented ESRD and chronic dialysis cost containment program aimed at helping payers capture Medicare savings immediately.

  • Buyer
    Charterhouse Capital Partners
    Target
    Animalcare Group
    Location
    England, United Kingdom
    Type
    Buyout

    Charterhouse Capital Partners has completed its acquisition of Animalcare Group after the animal healthcare company was delisted from the London Stock Exchange’s AIM market. Financial terms were not disclosed. The deal positions Animalcare as a platform for continued innovation, international expansion, and additional strategic acquisitions in the global animal health sector.

  • Buyer
    ACT LAB
    Target
    Sriven Labs (SV Labs – NJ)
    Type
    Addon

    ACT LAB, a multistate cannabis and hemp testing and compliance laboratory network, announced an expansion into New Jersey. The expansion follows its acquisition of Sriven Labs (SV Labs – NJ), a licensed cannabis testing laboratory serving New Jersey’s regulated cannabis market, and aims to improve local testing capacity and turnaround times while maintaining standardized methodologies.

  • Buyer
    Sheridan Capital Partners
    Target
    Carolina Components Group
    Seller
    John Cooling (retains an equity interest; founder is implied as continuing owner/board member)
    Type
    Buyout

    Sheridan Capital Partners has completed its investment in Carolina Components Group (CCG), a Durham, North Carolina-based provider of custom-engineered bioprocessing assemblies and ultra-pure components used in biopharmaceutical manufacturing. Concurrent with the investment, CCG named Maurice Phelan as its new CEO, while founder John Cooling joined the board and retains an equity interest.

  • Buyer
    Isto Biologics, Keensight Capital
    Target
    NovaBone Products LLC
    Seller
    Halma plc
    Type
    Addon

    Isto Biologics announced the acquisition of NovaBone Products LLC, a developer and manufacturer of synthetic bone graft products, from Halma plc. The deal, supported by Keensight Capital, adds NovaBone’s bioactive glass technologies to Isto’s bone graft substitutes platform and expands its geographic reach and surgical end-market presence.

  • Buyer
    Craftech Holdco (portfolio company of Sage Park), Sage Park
    Target
    Balda C. Brewer (BCB)
    Seller
    Stevanato Group S.p.A
    Type
    Addon

    Craftech Holdco, a portfolio company of Sage Park, acquired Balda C. Brewer (BCB), an Ontario, California-based contract manufacturing injection molding subsidiary, from Stevanato Group S.p.A. The deal expands the combined platform’s medical cleanroom injection molding capabilities and manufacturing footprint across the United States and Mexico.

  • Buyer
    Nordic Capital
    Target
    BWXT Medical, Kinectrics stable medical isotopes business
    Seller
    BWX Technologies, Inc. (BWXT)
    Location
    Canada

    BWX Technologies, Inc. (BWXT) has entered into a definitive agreement to sell its medical business to Nordic Capital for up to $800 million. The transaction includes BWXT Medical and Kinectrics’ stable medical isotopes business, and BWXT expects the deal to close by the end of 2026 subject to regulatory approvals.

  • Buyer
    Curium US Holdings LLC, Curium, CapVest Partners LLP
    Target
    Lantheus Holdings, Inc.
    Type
    Buyout

    Curium US Holdings LLC has entered into a definitive agreement to acquire all outstanding shares of Lantheus Holdings, Inc. for $102.50 per share in cash at closing, plus non-transferable Contingent Value Rights (CVRs) potentially paying up to an additional $12.00 per share tied to commercial milestones through 2030. The transaction is valued at up to approximately $8.0 billion and is expected to close in the first half of 2027, subject to customary approvals and regulatory clearances.

  • Buyer
    KKR
    Target
    Integer Holdings Corporation
    Seller
    Integer stockholders
    Type
    Buyout

    KKR has entered into a definitive agreement to acquire Integer Holdings Corporation in an all-cash transaction valued at approximately $5.7 billion. Under the terms of the deal, Integer shareholders will receive $127 per share, and the transaction is expected to close by the end of 2026 subject to customary approvals and closing conditions.

  • Buyer
    PetIQ
    Target
    MYOS Corp
    Type
    Buyout

    PetIQ acquired MYOS Corp and its Fortetropin-based muscle health product portfolio, adding consumer supplements and veterinarian-exclusive formulations to its pet health and wellness platform. The deal gives PetIQ ownership of the MYOS brand and patented Fortetropin ingredient technology, which it plans to scale using its national retail and e-commerce capabilities.

  • Buyer
    Apax Partners (affiliate of funds advised by Apax Partners)
    Target
    Centor, Gerresheimer Primary Packaging Plastics business
    Seller
    Gerresheimer

    Gerresheimer has entered into definitive agreements to sell Centor and its global Primary Packaging Plastics business to an affiliate of funds advised by Apax Partners, for an enterprise value of about €1.5 billion. The carve-out transactions will be completed through separate deals expected to close independently, subject to customary conditions and regulatory approvals, with Centor targeted for completion by the end of Gerresheimer’s 2026 fiscal year.

  • Buyer
    Lafayette Instrument, Branford Castle Partners
    Target
    Avisoft Bioacoustics
    Location
    Germany
    Type
    Addon

    Lafayette Instrument, a Branford Castle Partners portfolio company, has acquired Avisoft Bioacoustics to expand its life sciences research instrumentation portfolio. Avisoft supplies ultrasonic microphones, recording systems, and analytical software used in ultrasonic vocalization research for universities and research institutions. Financial terms were not disclosed.

  • Buyer
    All Star Healthcare Solutions, Knox Lane
    Target
    Cross Country Healthcare's locums division (Cross Country Locums)
    Seller
    Cross Country Healthcare, Inc.
    Type
    Addon

    All Star Healthcare Solutions acquired the locums division of Cross Country Healthcare, Inc. The acquired business will initially operate as “Cross Country Locums — an All Star Healthcare Solutions company.” The transaction was completed in conjunction with Knox Lane’s acquisition of Cross Country Healthcare.

  • Buyer
    Decera Clinical, The Riverside Company
    Target
    Onviv, Inc.
    Location
    United States

    The Riverside Company’s Decera Clinical invested in Onviv, Inc. The combination is intended to expand Decera Clinical’s healthcare insights and scientific engagement/medical communications capabilities, including accelerating Onviv’s go-to-market with Decera Clinical’s AI platform, ActivationOS.

  • Buyer
    Clarion Partners
    Target
    Clearwater at Sonoma Hills
    Type
    Buyout

    Clarion Partners acquired Clearwater at Sonoma Hills, a 94-unit senior living community in Rohnert Park, California, expanding its presence in Northern California’s senior housing market. Clearwater Living will continue as the property’s operating partner following the transaction.

  • Buyer
    Health Catalyst Capital (HCC)
    Target
    Midwest psychiatric care provider (leading practice serving elderly and disabled adults)
    Location
    United States

    Health Catalyst Capital (HCC), a New York-based private equity firm, acquired a leading Midwest provider of psychiatric care for elderly and disabled adults. MidCap Advisors served as the exclusive financial advisor and the practice plans to expand its regional footprint with HCC’s healthcare network and operational expertise.

  • Buyer
    Maxim Partners
    Target
    KGK Science Inc.
    Location
    Ontario, Canada

    KGK Science Inc. received a growth investment led by Maxim Partners to expand its clinical research and regulatory services. The transaction closed on June 30, 2026; financial terms were not disclosed.

  • Buyer
    Graham Partners
    Target
    TechData Service Company, LLC
    Seller
    Encore AMC Partners LLC (served as TechData’s exclusive financial advisor)
    Type
    Addon

    Graham Partners completed the July 1, 2026 acquisition of TechData Service Company, LLC (“TechData”) to anchor the newly formed Quantive Intelligence (“QI”) decision sciences platform. QI is being built through Graham’s acquisitions of TechData, LLX Solutions, LLC (“LLX”), and R Square Technology, Inc. (“R Square”), serving pharmaceutical and biotechnology sponsors with biostatistics, statistical programming, and data management services.

  • Buyer
    RS2 Healthcare Partners
    Target
    KMM Group
    Location
    United States

    KMM Group, a vertically integrated precision contract manufacturer for the medical device industry, announced the completion of an investment by RS2 Healthcare Partners. In connection with the investment, KMM appointed industry veteran J. Mark King as President and Chief Executive Officer, with co-founders John Shegda (Chief Technology Officer) and Eric Wilhelm (Executive VP, Business Transformation & Organizational Capability) taking key leadership roles.

  • Buyer
    Bain Capital
    Target
    Vitabiotics, the wider VB Group, Meyer Organics, VB Egypt
    Seller
    Lalvani family, selling party (unnamed)
    Location
    United Kingdom
    Type
    Buyout

    Bain Capital agreed to acquire Vitabiotics, the UK’s leading vitamin company, along with the wider VB Group, including Meyer Organics in India and operations in Africa (including VB Egypt). The deal is intended to support Vitabiotics’ next phase of planned rapid international growth, with the UK expected to remain central to its brand and innovation and no immediate changes to day-to-day operations.

  • Buyer
    SkyKnight Capital, L.P., FFL Partners
    Target
    Apex Infusion

    Apex Infusion entered into a definitive agreement to partner with private equity firm SkyKnight Capital to support the company’s next phase of growth. Apex’s clinician-led management team will retain a significant ownership stake and continue to lead, while FFL Partners will remain a minority investor.

  • Buyer
    leading middle market healthcare private equity fund
    Target
    The Skin Center
    Seller
    Footbridge Partners, ALZA Capital Partners
    Location
    United States

    The Skin Center, a portfolio company of Footbridge Partners and ALZA Capital Partners, was sold to a leading middle market healthcare private equity fund. Mesirow served as the exclusive financial advisor to The Skin Center, with the transaction described as a recapitalization aimed at accelerating growth across its med spa and cosmetic surgery locations.

  • Buyer
    Warburg Pincus Capital Solutions Founders Fund (WPCS FF), Goldman Sachs Alternatives, Sixth Street
    Target
    Paradigm Oral Health
    Seller
    BlackRock Long Term Private Capital (BlackRock LTPC)

    Paradigm Oral Health announced a buyback of BlackRock Long Term Private Capital’s ownership stake, returning majority control to its surgeons and management. The buyback is backed by an investment led by Warburg Pincus, in partnership with Goldman Sachs Alternatives and Sixth Street.

  • Buyer
    Beacon Behavioral Partners
    Target
    Pure Psychiatry
    Type
    Addon

    Beacon Behavioral Partners entered Michigan and Ohio through an acquisition partnership with Pure Psychiatry, adding a 17-location outpatient behavioral health platform. The deal provides Beacon with its first presence in both states as it expands its regional footprint, while Pure Psychiatry’s clinicians keep ownership stake and clinical autonomy. Financial terms were not disclosed.

Full Export

Purchase this data

Get the full acquisitions list for this page as CSV + XLSX.

Build a buyer list for your Healthcare Services deal

Find buyers actively acquiring healthcare services companies.

Apply as a Buyer

Related Acquisition Pages